JD Health lifts share count marginally amid ongoing HK$8.50 million buyback

Bulletin Express06-05 20:07

JD Health International Inc. disclosed a minor change in its capital structure following the issuance of 300,000 ordinary shares on 4 June 2026 under its Post-IPO Share Award Scheme. The new issue expanded the company’s outstanding share base by 0.009 %, taking the total to 3.21 billion shares as of 5 June 2026.

In parallel, the healthcare platform continued its share-repurchase programme. Between 15 May and 5 June 2026, JD Health bought back 16.17 million shares for cancellation, equal to 0.505 % of the share capital authorised in its June 2025 mandate. The most recent on-market repurchase on 5 June amounted to 225,400 shares at prices ranging from HK$37.62 to HK$37.80, for a total consideration of HK$8.50 million.

The repurchased shares have yet to be cancelled, and the company remains within the authorised limit of 320.01 million shares under the current buyback mandate. A 30-day moratorium on new share issues or treasury-share sales runs through 5 July 2026 following the latest repurchase activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment